Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
- Status
- TERMINATED
- Phase
- NA
Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE1
Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE2
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
American Ginseng in Treating Patients With Fatigue Caused by Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant
- Status
- COMPLETED
- Phase
- NA
Clofarabine for Myelodysplastic Syndrome (MDS) Patients Who Failed Vidaza Treatment (tx)
- Status
- TERMINATED
- Phase
- PHASE2
A Study Evaluating Epoetin Alfa 40,000 IU (International Units) Every Week or 80,000 IU Every Week Compared to Placebo in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes at Risk for Transfusion
- Status
- TERMINATED
- Phase
- PHASE3
LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Histone-deacetylase Inhibitor JNJ-26481585 in Patients With Advanced or Refractory Leukemia or Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE1
Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload
- Status
- COMPLETED
- Phase
- PHASE4
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
- Status
- COMPLETED
- Phase
- PHASE3
Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood
- Status
- RECRUITING
- Phase
- N/A
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- N/A
Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1